RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
TBG Diagnostics Stock

TBG Diagnostics ROE 2024

TBG Diagnostics ROE

0

Ticker

TDL.AX

ISIN

AU000000TDL4

WKN

A2AD8F

In 2024, TBG Diagnostics's return on equity (ROE) was 0, a 0% increase from the 0 ROE in the previous year.

TBG Diagnostics Aktienanalyse

What does TBG Diagnostics do?

TBG Diagnostics Ltd is an Australian company specializing in the manufacturing and marketing of in vitro diagnostic products. The company was originally founded in 2009 under the name TBG Biotechnology Pty Ltd and later became a corporation. The company's business model is to provide fast and reliable diagnostic solutions for various disease conditions. The company operates in various areas, including infectious diseases, diarrheal diseases, tumor diagnostics, cardiovascular diseases, and oncology. In the infectious diseases field, for example, TBG Diagnostics offers test kits for the diagnosis of HIV, hepatitis, dengue fever, and other infectious diseases. The test kits consist of immunological rapid tests that typically provide results within 15-20 minutes, allowing doctors to quickly make a diagnosis and initiate appropriate therapy. In the diarrheal diseases field, the company has developed a special test kit that allows for the detection of rotaviruses. Rotavirus infections are one of the most common causes of severe diarrhea in infants and can lead to serious complications if left untreated. TBG Diagnostics' tumor diagnostics division offers specialized test kits for the diagnosis of prostate cancer, breast cancer, and colorectal cancer. The test kits are based on the measurement of tumor markers in the blood and are a fast and non-invasive method for early cancer detection. The company's cardiovascular division offers test kits for the diagnosis of thyroid hormones and troponin. Troponin is a protein complex that is released into the blood in increased amounts when there is damage to the heart muscle and can be an indication of a heart attack. In collaboration with partners, TBG Diagnostics also develops innovative solutions for oncology. One example is a special test kit that enables personalized medicine for patients with advanced bladder cancer. The test kit analyzes the DNA of tumor cells and allows doctors to find individually tailored therapies for the patient. TBG Diagnostics is a successful company that has experienced steady growth in recent years. The company is listed on the Australian stock exchange and has a strong international distribution network, enabling it to distribute its products worldwide. Overall, TBG Diagnostics is a company specializing in the development and manufacturing of innovative diagnostic products. By focusing on various areas and collaborating with partners, the company can quickly respond to changing requirements in healthcare and offer customized solutions to its customers. TBG Diagnostics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding TBG Diagnostics's Return on Equity (ROE)

TBG Diagnostics's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing TBG Diagnostics's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

TBG Diagnostics's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in TBG Diagnostics’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about TBG Diagnostics stock

What is the ROE (Return on Equity) of TBG Diagnostics this year?

The ROE of TBG Diagnostics this year is 0 undefined.

How has the Return on Equity (ROE) of TBG Diagnostics developed compared to the previous year?

The ROE of TBG Diagnostics has increased by 0% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of TBG Diagnostics?

A high ROE indicates that TBG Diagnostics generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of TBG Diagnostics?

A low ROE can indicate that TBG Diagnostics is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of TBG Diagnostics affect the company?

A change in ROE (Return on Equity) of TBG Diagnostics can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of TBG Diagnostics?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of TBG Diagnostics?

Some factors that can influence TBG Diagnostics's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does TBG Diagnostics pay?

Over the past 12 months, TBG Diagnostics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, TBG Diagnostics is expected to pay a dividend of 0 AUD.

What is the dividend yield of TBG Diagnostics?

The current dividend yield of TBG Diagnostics is .

When does TBG Diagnostics pay dividends?

TBG Diagnostics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of TBG Diagnostics?

TBG Diagnostics paid dividends every year for the past 0 years.

What is the dividend of TBG Diagnostics?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is TBG Diagnostics located?

TBG Diagnostics is assigned to the 'Health' sector.

Wann musste ich die Aktien von TBG Diagnostics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of TBG Diagnostics from 11/14/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 11/14/2024.

When did TBG Diagnostics pay the last dividend?

The last dividend was paid out on 11/14/2024.

What was the dividend of TBG Diagnostics in the year 2023?

In the year 2023, TBG Diagnostics distributed 0 AUD as dividends.

In which currency does TBG Diagnostics pay out the dividend?

The dividends of TBG Diagnostics are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von TBG Diagnostics

Our stock analysis for TBG Diagnostics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of TBG Diagnostics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.